Comment on Why Didn't Investors Care About This Marijuana Stock's Big News?

Why Didn't Investors Care About This Marijuana Stock's Big News?

It's been a rough couple of months for GW Pharmaceuticals (NASDAQ: GWPH). The stock sank in February after the biotech reported a major disappointment for its cannabidivarin (CBDV) compound GWP42006 in a phase 2a clinical study targeting treatment of focal seizures. But the cannabinoid-focused biotech announced important good news last week related to its lead product Epidiolex.

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News